Jubilant HollisterStier LLC
Jubilant HollisterStier LLC (United States) holds 2 active US FDA Type II Drug Master Files. 38 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Jubilant HollisterStier LLC: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/jubilant-hollisterstier-llc
Overview
Jubilant HollisterStier LLC is a global pharmaceutical and life sciences company offering contract manufacturing services. As a subsidiary of Jubilant Pharma, it specializes in providing sterile injectable, allergenic extract, and non-sterile production and manufacturing services along with research and development support.
Core services & business areas
Therapeutic areas
API / Drug Master Files
Jubilant HollisterStier LLC holds 2 active (2 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- STERILE EMPTY VIALSActive2011-11-15
- STERILE EVACUATED VIALSActive2011-08-04
FDA compliance signals
38 FDA enforcement records linked to this company.
- 4832015-07-31
Investigations of discrepancies, failures
- 4832014-04-15
Calculations performed are in the records
- 4832014-04-15
Authority lacking to review records, investigate errors
- 4832014-04-15
Training--operations, GMPs, written procedures
- 4832014-04-15
Cleaning System
- 4832014-04-15
Lab written procedures
- 4832014-04-15
Signatures and dates--person who performs test
- 4832014-04-15
Computer control of master formula records
- 4832014-04-15
Microbiological testing
- 4832014-04-15
Drug product sample
- 4832014-04-15
Scientifically sound laboratory controls
- 4832014-04-15
Procedures not in writing, fully followed
- 4832014-04-15
Drug products - samples representative, identified properly
- 4832014-04-15
Procedures for sterile drug products
- 4832014-04-15
Sterility/pyrogens - test methods written, followed
- 4832014-04-15
Absence of Written Procedures
- 4832014-04-15
Procedures To Be in Writing
- 4832014-04-15
Complete Test Data
- 4832014-04-15
Mixing adequacy
- warning_letter2013-11-27
FDA Warning Letter (drug product)
- 4832013-05-10
Written record of investigation incomplete
- 4832013-05-10
Stability sample storage conditions described
- 4832013-05-10
Control procedures to monitor and validate performance
- 4832013-05-10
Cleaning System
- 4832013-05-10
Authority lacking to review records, investigate errors
- 4832013-05-10
Training--operations, GMPs, written procedures
- 4832013-05-10
In-process materials specifications
- 4832013-05-10
Environmental Monitoring System
- 4832013-05-10
Procedures for sterile drug products
- 4832013-05-10
Cleaning / Sanitizing / Maintenance
- 4832013-05-10
Following/documenting laboratory controls
- 4832013-05-10
Written program not followed
- 4832013-05-10
Written in-process control procedures
- 4832009-05-08
Procedures for sterile drug products
- 4832009-05-08
Equipment to control conditions
- 4832009-05-08
Test methods
- 4832009-05-08
Validation lacking for sterile drug products
- 4832009-05-08
Documentation of Sampling Performed
Is this Jubilant HollisterStier LLC?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.